Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, DRI Healthcare Trust's Enterprise Value is €915.1 Mil.
DRI Healthcare Trust's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was €38.2 Mil. Therefore, DRI Healthcare Trust's EV-to-FCF for today is 23.93.
The historical rank and industry rank for DRI Healthcare Trust's EV-to-FCF or its related term are showing as below:
FRA:3IJ0'
s EV-to-FCF Range Over the Past 10 Years
Min: -139.59 Med: -2.32 Max: 46.43
Current: 24.49
During the past 5 years, the highest EV-to-FCF of DRI Healthcare Trust was 46.43. The lowest was -139.59. And the median was -2.32.
FRA:3IJ0's EV-to-FCF is ranked worse than 56.16% of 568
companies
in the Drug Manufacturers industry
Industry Median: 20.11
vs FRA:3IJ0: 24.49
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
DRI Healthcare Trust's PE Ratio (TTM) for today is calculated as:
DRI Healthcare Trust's share price for today is €10.076.
DRI Healthcare Trust's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.689.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
DRI Healthcare Trust EV-to-FCF Related Terms
DRI Healthcare Trust EV-to-FCF Historical Data
* Premium members only.
The historical data trend for DRI Healthcare Trust's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DRI Healthcare Trust EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where DRI Healthcare Trust's EV-to-FCF falls into.
DRI Healthcare Trust's current Enterprise Value is €915.1 Mil.
DRI Healthcare Trust's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €38.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRI Healthcare Trust (FRA:3IJ0) has a EV-to-FCF of 23.93 as of Sep. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on DRI Healthcare Trust and its competitors. According to the industry distribution chart, DRI Healthcare Trust ranks #319 out of 568 companies in the Drug Manufacturers industry, placing it in the top 56.2%.
Is DRI Healthcare Trust's EV-to-FCF too high?
DRI Healthcare Trust's current EV-to-FCF is 23.93. The Drug Manufacturers industry median EV-to-FCF is 20.11. DRI Healthcare Trust's value of 23.93 is 19% above this industry median. Based on the distribution chart, DRI Healthcare Trust ranks #319 out of 568 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DRI Healthcare Trust has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does DRI Healthcare Trust's EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DRI Healthcare Trust ranks #319 out of 568 companies for EV-to-FCF. This places DRI Healthcare Trust in the lower half of its industry. The industry median EV-to-FCF is 20.11. DRI Healthcare Trust's value of 23.93 is 19% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.11, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DRI Healthcare Trust's current EV-to-FCF of 23.93 is 19% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on DRI Healthcare Trust and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DRI Healthcare Trust's current EV-to-FCF is 23.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DRI Healthcare Trust stock overvalued right now?
DRI Healthcare Trust (FRA:3IJ0) has a current EV-to-FCF of 23.93. The stock's GF Value™ is €11.43, compared to a current price of €10.08 — trading 11.8% below its estimated fair value. The current EV-to-FCF is 23.93 and 19% above the Drug Manufacturers industry median of 20.11. DRI Healthcare Trust's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For DRI Healthcare Trust (FRA:3IJ0), the current EV-to-FCF is 23.93 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DRI Healthcare Trust (FRA:3IJ0) Overvalued in 2026?
Based on GuruFocus' analysis, DRI Healthcare Trust stock appears to be undervalued.
The current stock price of €10.08 is trading 11.8% below its estimated GF Value™ of €11.43.
Key valuation signals for FRA:3IJ0:
EV-to-FCF: 23.93
GF Value™: €11.43 vs. price of €10.08 (11.8% below fair value)
Industry Position: 19% above the Drug Manufacturers median (#319 of 568)
No single metric tells the full story. See the FRA:3IJ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.
53GF Score
Get the complete analysis for FRA:3IJ0
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3IJ0 has been successfully added to your 
